Piper Sandler is sticking to its S&P 500 (SP500) year-end target of 6,600 points, despite the recent dip in the benchmark index that saw it slip into correction territory. For Piper Sandler's ...

March 21 - Piper Sandler (PIPR, Financial) is sticking to its bullish stance on the S&P 500, holding firm on its year-end target of 6,600 points despite recent market turbulence. The index ...

CVS Health (NYSE:CVS – Free Report) had its target price hoisted by Piper Sandler from $72.00 to $74.00 in a research note issued to investors on Friday morning,Benzinga reports.Piper Sandler ...

On Friday, Piper Sandler adjusted its stance on TELA Bio, Inc. (NASDAQ:TELA), downgrading the stock from Overweight to Neutral and reducing the price target significantly to $2.00 from the ...

NASDAQ ACVA opened at $15.31 on Thursday. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.56 and a current ratio of 1.56. The firm has a market cap of $2.58 billion, a PE ratio ...

Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) had its price objective lowered by Piper Sandler from $36.00 to $32.00 in a report published on Friday,Benzinga reports. The firm currently ...

NASDAQ OLLI opened at $106.88 on Thursday. The company has a market capitalization of $6.55 billion, a PE ratio of 31.90, a price-to-earnings-growth ratio of 2.21 and a beta of 0.83. Ollie’s ...

In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Edgewise Therapeutics (EWTX – Research Report), with a price target of $51.00. The company’s shares ...

Shares of NASDAQ IPSC opened at $0.56 on Thursday. The stock has a market cap of $47.19 million, a price-to-earnings ratio of -0.30 and a beta of 1.75. The business has a 50 day simple moving ...

Aptiv (NYSE:APTV – Get Free Report) had its target price increased by equities research analysts at Piper Sandler from $65.00 to $67.00 in a report released on Thursday,Benzinga reports.

On Friday, Elevation Oncology shares faced a significant adjustment as Piper Sandler analyst Biren Amin downgraded the stock from Overweight to Neutral. This revision came with a steep reduction ...

Piper Sandler lowered shares of Rivian Automotive (NASDAQ:RIVN – Free Report) from an overweight rating to a neutral rating in a research note released on Thursday, Marketbeat reports.